Ligand validation:6AOL

P33: 3,6,9,12,15,18-HEXAOXAICOSANE-1,20-DIOL

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6AOL_P33_A_402	25%	62%	0.152	0.933	0.59	0.87	-	-	0	0	18%	18.18
6AOL_P33_A_405	14%	60%	0.174	0.872	0.61	0.9	-	-	1	0	18%	18.18
6AOL_P33_A_403	7%	41%	0.287	0.824	0.81	1.46	-	1	0	0	50%	0.5
6AOL_P33_A_404	3%	61%	0.359	0.851	0.59	0.89	-	-	1	0	18%	18.18
6AOM_P33_A_407	43%	62%	0.187	0.909	0.76	0.71	-	-	2	0	100%	1
5L2V_P33_A_202	81%	60%	0.11	0.962	0.46	1.06	-	1	0	0	100%	0.5
3B1Q_P33_A_331	70%	50%	0.106	0.922	0.6	1.3	-	3	4	0	100%	1
8BK2_P33_L_301	66%	70%	0.121	0.926	0.53	0.63	-	1	3	0	100%	1
8CCQ_P33_A_2013	65%	66%	0.113	0.914	0.58	0.74	-	-	2	0	100%	1
2Y2U_P33_B_1545	64%	47%	0.146	0.963	0.52	1.49	-	1	3	0	91%	0.9091

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.